The Viral Latency-associated Nuclear Antigen Augments the B-cell Response to Antigen in Vivo
Overview
Affiliations
Gammaherpesviruses, including Kaposi sarcoma-associated herpesvirus (KSHV), establish latency in B cells. We hypothesized that the KSHV latency-associated nuclear antigen (LANA/orf73) provides a selective advantage to infected B cells by driving proliferation in response to antigen. To test this, we used LANA B-cell transgenic mice. Eight days after immunization with antigen without adjuvant, LANA mice had significantly more activated germinal center (GC) B cells (CD19(+) PNA(+) CD71(+)) than controls. This was dependent upon B-cell receptor since LANA did not restore the GC defect of CD19 knockout mice. However, LANA was able to restore the marginal zone defect in CD19 knockout mice.
Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV).
Shifflett K, Dittmer D Virology. 2025; 603:110384.
PMID: 39837218 PMC: 11788063. DOI: 10.1016/j.virol.2024.110384.
Sin S, Eason A, Kim Y, Schneider J, Damania B, Dittmer D Cell Host Microbe. 2024; 32(5):755-767.e4.
PMID: 38653242 PMC: 11305081. DOI: 10.1016/j.chom.2024.03.012.
Cancers associated with human gammaherpesviruses.
Wen K, Wang L, Menke J, Damania B FEBS J. 2021; 289(24):7631-7669.
PMID: 34536980 PMC: 9019786. DOI: 10.1111/febs.16206.
Extracellular vesicles in virus infection and pathogenesis.
McNamara R, Dittmer D Curr Opin Virol. 2020; 44:129-138.
PMID: 32846272 PMC: 7755726. DOI: 10.1016/j.coviro.2020.07.014.
Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus.
Bravo Cruz A, Damania B J Virol. 2019; 93(11).
PMID: 30867309 PMC: 6532075. DOI: 10.1128/JVI.01053-18.